NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.74 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.74 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 101 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
% | $1.99 Billion | Healthcare | Biotechnology | $18.82 | -0.69% |
| 102 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
% | $1.94 Billion | Healthcare | Biotechnology | $40.59 | -2.78% |
| 103 |
AnaptysBio Inc
NASDAQ:ANAB |
% | $1.93 Billion | Healthcare | Biotechnology | $69.81 | +5.15% |
| 104 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
% | $1.93 Billion | Healthcare | Biotechnology | $22.71 | -1.52% |
| 105 |
Mesoblast Ltd
NASDAQ:MESO |
% | $1.92 Billion | Healthcare | Biotechnology | $16.22 | +5.05% |
| 106 |
ADMA Biologics Inc
NASDAQ:ADMA |
% | $1.90 Billion | Healthcare | Biotechnology | $8.97 | -1.21% |
| 107 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
% | $1.89 Billion | Healthcare | Biotechnology | $22.89 | -3.05% |
| 108 |
Galapagos NV ADR
NASDAQ:GLPG |
% | $1.89 Billion | Healthcare | Biotechnology | $28.68 | -1.58% |
| 109 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
% | $1.86 Billion | Healthcare | Biotechnology | $35.54 | -3.53% |
| 110 |
Novocure Ltd
NASDAQ:NVCR |
% | $1.86 Billion | Healthcare | Medical Devices | $16.09 | -1.29% |
| 111 |
Stoke Therapeutics Inc
NASDAQ:STOK |
% | $1.83 Billion | Healthcare | Biotechnology | $29.46 | -6.12% |
| 112 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
% | $1.80 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $81.08 | -1.21% |
| 113 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
% | $1.79 Billion | Healthcare | Biotechnology | $24.94 | -3.63% |
| 114 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
% | $1.76 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $15.50 | +0.00% |
| 115 |
Tyra Biosciences Inc
NASDAQ:TYRA |
% | $1.76 Billion | Healthcare | Biotechnology | $32.67 | -0.24% |
| 116 |
Vericel Corp Ord
NASDAQ:VCEL |
% | $1.73 Billion | Healthcare | Biotechnology | $47.49 | +1.04% |
| 117 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
% | $1.73 Billion | Healthcare | Biotechnology | $3.30 | -7.30% |
| 118 |
Agios Pharm
NASDAQ:AGIO |
% | $1.71 Billion | Healthcare | Biotechnology | $40.55 | -1.65% |
| 119 |
Innoviva Inc
NASDAQ:INVA |
% | $1.66 Billion | Healthcare | Biotechnology | $22.21 | -0.13% |
| 120 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
% | $1.64 Billion | Healthcare | Biotechnology | $32.49 | +1.69% |
| 121 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
% | $1.64 Billion | Healthcare | Biotechnology | $17.41 | -2.03% |
| 122 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
% | $1.64 Billion | Healthcare | Biotechnology | $21.98 | -4.60% |
| 123 |
Abcellera Biologics Inc
NASDAQ:ABCL |
% | $1.61 Billion | Healthcare | Biotechnology | $6.52 | -4.12% |
| 124 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
% | $1.56 Billion | Healthcare | Biotechnology | $33.64 | -0.15% |
| 125 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
% | $1.55 Billion | Healthcare | Biotechnology | $5.38 | -15.14% |
| 126 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
% | $1.54 Billion | Healthcare | Biotechnology | $13.02 | -8.41% |
| 127 |
Precigen Inc
NASDAQ:PGEN |
% | $1.50 Billion | Healthcare | Biotechnology | $5.17 | -2.82% |
| 128 |
Novavax Inc
NASDAQ:NVAX |
% | $1.47 Billion | Healthcare | Biotechnology | $8.91 | -4.50% |
| 129 |
Uniqure NV
NASDAQ:QURE |
% | $1.46 Billion | Healthcare | Biotechnology | $41.10 | -3.59% |
| 130 |
Vir Biotechnology Inc
NASDAQ:VIR |
% | $1.44 Billion | Healthcare | Biotechnology | $9.72 | -2.41% |
| 131 |
UroGen Pharma Ltd
NASDAQ:URGN |
% | $1.43 Billion | Healthcare | Biotechnology | $39.51 | +2.46% |
| 132 |
Harrow Health Inc
NASDAQ:HROW |
% | $1.42 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $41.81 | -1.58% |
| 133 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
% | $1.41 Billion | Healthcare | Biotechnology | $8.16 | -2.16% |
| 134 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
% | $1.35 Billion | Healthcare | Biotechnology | $92.17 | -0.91% |
| 135 |
Compass Pathways Plc
NASDAQ:CMPS |
% | $1.34 Billion | Healthcare | Medical Care Facilities | $13.19 | -3.34% |
| 136 |
Ardelyx Inc
NASDAQ:ARDX |
% | $1.27 Billion | Healthcare | Biotechnology | $5.14 | -2.65% |
| 137 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
% | $1.24 Billion | Healthcare | Biotechnology | $14.71 | -6.13% |
| 138 |
Tourmaline Bio Inc.
NASDAQ:TRML |
% | $1.23 Billion | Healthcare | Biotechnology | $47.98 | +0.00% |
| 139 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
% | $1.18 Billion | Healthcare | Biotechnology | $14.28 | -2.99% |
| 140 |
MannKind Corp
NASDAQ:MNKD |
% | $1.16 Billion | Healthcare | Biotechnology | $4.04 | -1.22% |
| 141 |
Wave Life Sciences Ltd
NASDAQ:WVE |
% | $1.14 Billion | Healthcare | Biotechnology | $5.95 | -4.80% |
| 142 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
% | $1.13 Billion | Healthcare | Biotechnology | $21.53 | +0.00% |
| 143 |
Collegium Pharmaceutical Inc
NASDAQ:COLL |
% | $1.10 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $34.82 | -1.16% |
| 144 |
Savara Inc
NASDAQ:SVRA |
% | $1.05 Billion | Healthcare | Biotechnology | $5.74 | -4.81% |
| 145 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
% | $1.03 Billion | Healthcare | Biotechnology | $4.04 | -4.49% |
| 146 |
Absci Corp
NASDAQ:ABSI |
% | $1.01 Billion | Healthcare | Biotechnology | $10.21 | -3.68% |
| 147 |
Sana Biotechnology Inc
NASDAQ:SANA |
% | $1.01 Billion | Healthcare | Biotechnology | $3.64 | -5.45% |
| 148 |
Pacira BioSciences, Inc.
NASDAQ:PCRX |
% | $1.00 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $25.54 | +0.24% |
| 149 |
Verve Therapeutics Inc
NASDAQ:VERV |
% | $994.04 Million | Healthcare | Biotechnology | $11.13 | +0.00% |
| 150 |
Kura Oncology Inc
NASDAQ:KURA |
% | $968.53 Million | Healthcare | Biotechnology | $10.91 | -4.72% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices